Compare AMR & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | AMR | HTFL |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | N/A | 2025 |
| Metric | AMR | HTFL |
|---|---|---|
| Price | $190.91 | $26.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $180.50 | $39.20 |
| AVG Volume (30 Days) | 265.9K | ★ 1.7M |
| Earning Date | 02-27-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,226,356,000.00 | $161,881,000.00 |
| Revenue This Year | N/A | $40.42 |
| Revenue Next Year | $18.91 | $22.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 85.70 |
| 52 Week Low | $97.41 | $25.38 |
| 52 Week High | $253.82 | $41.22 |
| Indicator | AMR | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 37.63 |
| Support Level | $200.46 | $25.60 |
| Resistance Level | $212.01 | $29.86 |
| Average True Range (ATR) | 10.40 | 2.07 |
| MACD | -4.62 | -0.51 |
| Stochastic Oscillator | 11.52 | 11.96 |
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.